Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy

NCT02439216 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscular Dystrophy, Duchenne

Interventions

DRUG: Edasalonexent
DRUG: Placebo

Sponsor

Catabasis Pharmaceuticals